Efficacy and safety of peri-procedural bridging therapy with low molecular weight heparin in atrial fibrillation patients under vitamin K antagonists-Reference-Cited by-同舟云学术

Efficacy and safety of peri-procedural bridging therapy with low molecular weight heparin in atrial fibrillation patients under vitamin K antagonists

Published:2018-10-31 Issue:3 Volume:112 Page:183-188
ISSN:1460-2725
Container-title:QJM: An International Journal of Medicine
language:en
Short-container-title:

Author:

Ríos S J¹,Rivera-Caravaca J M²^ORCID,Aroca-Valverde C¹,Reguilón-Gallego L¹,Castillo-Rodríguez M¹,Esteve-Pastor M A²,Vicente V¹,Marín F²,Roldán V¹

Affiliation:

1. Department of Hematology and Clinical Oncology, Hospital General Universitario Morales Meseguer, Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), Murcia, Spain

2. Department of Cardiology, Hospital Clínico Universitario Virgen de la Arrixaca, Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), CIBER-CV, Murcia, Spain

Funder

Instituto de Salud Carlos III

Fondo Europeo de Desarrollo Regional

Fundación Séneca

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

http://academic.oup.com/qjmed/article-pdf/112/3/183/27988775/hcy250.pdf

Reference20 articles.

1. Atrial fibrillation: epidemiology, pathophysiology, and clinical outcomes;Staerk;Circ Res,2017